The Securities Commission has granted Reunion Neuroscience Inc. (the Filer) an order to cease being a reporting issuer in all Canadian jurisdictions where it held this status. The decision is based on the Filer meeting several conditions: it is not an OTC reporting issuer, its securities are owned by fewer than 15 security holders in each jurisdiction in Canada and less than 51 worldwide, its securities are not traded on any public marketplace, and it is not in default of any securities legislation. The order is supported by the Securities Act, R.S.O. 1990, c. S.5, as amended, specifically section 1(10)(a)(ii), and is consistent with the test set out in the relevant legislation. The Ontario Securities Commission, acting as the principal regulator, has approved the application following the Process for Cease to be a Reporting Issuer Applications, with the decision also applying to several other Canadian provinces through Multilateral Instrument 11-102 Passport System.
